Page last updated: 2024-11-02

piribedil and Emesis

piribedil has been researched along with Emesis in 2 studies

Piribedil: A dopamine D2 agonist. It is used in the treatment of parkinson disease, particularly for alleviation of tremor. It has also been used for circulatory disorders and in other applications as a D2 agonist.

Research Excerpts

ExcerptRelevanceReference
" One of these, piribedil, was administered as 0,1 mg/kg intravenously over 30 minutes to 150 subjects with either migraine or other types of headache."3.66[Value of the piribedil test in diagnosing migraine. Apropos of 150 cases]. ( Bès, A; Courtade, M; Dupui, P; Géraud, G; Guell, A, 1983)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Géraud, G1
Bès, A1
Courtade, M1
Dupui, P1
Guell, A1
Angrist, B1
Thompson, H1
Shopsin, B1
Gershon, S1

Other Studies

2 other studies available for piribedil and Emesis

ArticleYear
[Value of the piribedil test in diagnosing migraine. Apropos of 150 cases].
    Revue neurologique, 1983, Volume: 139, Issue:3

    Topics: Adult; Blood Pressure; Diagnosis, Differential; Female; Headache; Humans; Male; Middle Aged; Migrain

1983
Clinical studies with dopamine-receptor stimulants.
    Psychopharmacologia, 1975, Nov-21, Volume: 44, Issue:3

    Topics: Adult; Apomorphine; Blood Pressure; Dopamine; Female; Hallucinations; Humans; Male; Metoclopramide;

1975